Accelerating Progress: ALS Research Updates from the Field

Research is a key mission strategy in our goal to find treatments and a cure for ALS.  Join us on July 21 to learn about research going on currently in the state of Alabama – including news from Dr. Peter King, physician and ALS Researcher at The University of Alabama Birmingham and Birmingham VA Medical Director.  We will also have an important presentation by Dr.Paul Meta, Principal Investigator with the CDC ALS Registry and Biorepository on the importance of the National Registry and how every person living with ALS can support research through the registry.

Image

Paul Mehta, MD

Physician/Principal Investigator of the National ALS Registry, Centers for Disease Control and Prevention

Dr. Mehta is the Principal Investigator for the United States congressionally-mandated National Amyotrophic Lateral Sclerosis (ALS) Registry which resides within the Centers for Disease Control and Prevention and is responsible for providing medical, scientific, and epidemiological expertise on matters related to ALS. Prior to joining ATSDR, Dr. Mehta was responsible for overseeing external research initiatives for the National Center for Environmental Health (NCEH) and ATSDR. Dr. Mehta started his career at the CDC as a Team Leader for the Division of Select Agents and Toxins (DSAT) where he was responsible for CDC’s Etiological Agent Import Permit Program (EAIPP) as well as conducting audits of high containment laboratories nationally. He has a Doctor of Medicine (MD) from Fatima Medical Science Foundation and a Bachelor of Arts in Biology from the University of Toledo.